End of Life Care Flashcards

1
Q

What are the principles for managing the last 48h of life?

A
  • Problem solving approach to symptom control
  • Avoid unnecessary interventions
  • Review drugs and symptoms regularly
  • Maintain effective communication
  • Ensure support for family and carers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do patients experience in the final 48 hours of life?

A
  • Increasing weakness and immobility
  • Loss of interest in food and drink
  • Difficulty swallowing
  • Drowsiness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Method of analgesic delivery and drug of choice if oral administration no longer possible?

A

S/C

Drug = diamorphine (strong opioid of choice; soluble). Delivered through syringe driver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Protocol for starting longer acting opioid preparations in patients close to death (i.e. transdermal fentanyl)?

A

DON’T! Should not be started in patient close to death.

  • variable delay in reaching effective levels
  • speedy dose titration difficult therefore unsuitable when rapid effect required (i.e. uncontrolled pain)
  • if pt already prescribed fentanyl patches, continue as baseline; add morphine / diamorphine titrated to pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bone pain therapeutic class best used?

A

NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Best analgesic class to ease pain of muscle spasm?

A

Diazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Opioid treatment starting dose (pain control during palliation)?

A

Immediate release morphine

  • 5mg every 4h
  • PO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Increment to increase by when titrating pain medication during palliation?

A

1/3 current dose (but varies according to breakthrough analgesia in previous 24h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Breakthrough analgesia dose?

A

1/6 24h dose

i.e. diamorphine 60mg S/C 24h ==> 10mg S/C PRN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Morphine PO to S/C conversion?

A

3:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Management of breathlessness in palliative stages?

A
  • Reverse reversible
  • Supportive measures: explanation, position, breathing exercises, fan or cool airflow, relaxation techniques
  • Oxygen therapy
  • Opioid
  • Benzo
  • Hyoscine
  • Nebulised saline (if no bronchospasm and patient able to expectorate)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management noisy terminal breathing?

A
  • Reposition
  • Hyoscine hydrobromide (if significant secretions)
  • > 0.4-0.6mg S/C bolus
  • > 2.4mg/24h via syringe driver
  • gentle suction sometimes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of restlessness and confusion?

A
  • Drugs: opioids, corticosteroids, neuroleptics, EtOH (intoxication and withdrawal)
  • Physical: unrelieved pain, distended bladder or bowel, immobility or exhaustion, cerebral lesions, infection, major organ failure
  • Metabolic upset: urea, calcium, sodium, glucose, hypoxia
  • Anxiety and distress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mx restlessness and confusion?

A
  • Treat acute state and address cause
  • Environment: stable, safe, soft light, quiet, familiar faces
  • Drug choice relates to likely cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indications and dose for haloperidol for mx restlessness?

A

-Drug toxicity
-Altered sensorium
-metabolic upset
>PO 1.5-3mg (rpt after 1h)
>S/C bolus 2.5-10mg
>S/C infusion 5-30mg 24h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications and dose for midazolam for mx restlessness?

A

Anxiety and distress; risk of seizure.
>S/C bolus 2.5-10mg
>S/C infusion 5-100mg 24h

17
Q

What should be used for altered sensorium plus anxiety management?

A

Combine haloperidol and midazolam

18
Q

Site of effect and treatment of choice for N/V due to drugs or biochemical upset?

A

Chemoreceptor trigger zone (area postrema) via dopamine receptors
Rx: haloperidol

19
Q

Site of effect and treatment of choice for N/V due to raised ICP?

A

Vomiting centres via histamine receptors

Rx: cyclizine

20
Q

Site of effect and treatment of choice for N/V due to uncertain/multifactorial?

A

Various sites.

Rx: Methotrimeprazine

21
Q

Site of effect and treatment of choice for N/V due to gastrointestinal stasis?

A

Gastrokinetic

Rx: metoclopramide, cisapride

22
Q

Site of effect and treatment of choice for N/V due to bowel obstruction?

A

Vomiting centres via vagus nerve; GIT secretions

Rx: cyclizine, octreotide, hyoscine butylbromide

23
Q

What are risk factors for bereavement?

A
  • Pt: young
  • Illness: short, protracted, disfiguring, distressing
  • Death: sudden, traumatic
  • Relationship: ambivalent, hostile, dependent
  • Main carer: young, other dependents, concurrent crises